A study to find out how healthy people tolerate a new drug called S221237.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519381-53-00

Acronym

CL1-221237-002

Enrollment

103

Registered

2024-11-13

Start date

2022-10-04

Completion date

2024-10-14

Last updated

2024-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson disease (PD)

None listed

Sex/Gender

All

Age

18 Years to No maximum

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026